• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

β-地中海贫血由于内含子中的 LINE-1 插入到β-珠蛋白基因(HBB)中:β-珠蛋白(L1)等位基因转录水平降低的分子机制。

β-Thalassemia due to intronic LINE-1 insertion in the β-globin gene (HBB): molecular mechanisms underlying reduced transcript levels of the β-globin(L1) allele.

机构信息

Department of Biology, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic; Departments of Medicine, Pathology and Genetics, University of Utah and Medical Service, George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, Utah.

出版信息

Hum Mutat. 2013 Oct;34(10):1361-5. doi: 10.1002/humu.22383. Epub 2013 Aug 13.

DOI:10.1002/humu.22383
PMID:23878091
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4993193/
Abstract

We describe the molecular etiology of β(+)-thalassemia that is caused by the insertion of the full-length transposable element LINE-1 (L1) into the intron-2 of the β-globin gene (HBB). The transcript level of the affected β-globin gene was severely reduced. The remaining transcripts consisted of full-length, correctly processed β-globin mRNA and a minute amount of three aberrantly spliced transcripts with a decreased half-life due to activation of the nonsense-mediated decay pathway. The lower steady-state amount of mRNA produced by the β-globin(L1) allele also resulted from a reduced rate of transcription and decreased production of full-length β-globin primary transcripts. The promoter and enhancer sequences of the β-globin(L1) allele were hypermethylated; however, treatment with a demethylating agent did not restore the impaired transcription. A histone deacetylase inhibitor partially reactivated the β-globin(L1) transcription despite permanent β-globin(L1) promoter CpG methylation. This result indicates that the decreased rate of transcription from the β-globin(L1) allele is associated with an altered chromatin structure. Therefore, the molecular defect caused by intronic L1 insertion in the β-globin gene represents a novel etiology of β-thalassemia.

摘要

我们描述了β(+)-地中海贫血的分子病因,该病是由全长转座元件 LINE-1(L1)插入β-珠蛋白基因(HBB)的内含子 2 引起的。受影响的β-珠蛋白基因的转录本水平严重降低。剩余的转录本包括全长、正确加工的β-珠蛋白 mRNA 和少量三种异常剪接的转录本,由于无意义介导的衰变途径的激活,半衰期缩短。β-珠蛋白(L1)等位基因产生的 mRNA 稳态量较低也归因于转录率降低和全长β-珠蛋白初级转录本产量减少。β-珠蛋白(L1)等位基因的启动子和增强子序列发生超甲基化;然而,用去甲基化剂处理并没有恢复受损的转录。尽管β-珠蛋白(L1)启动子 CpG 永久甲基化,但组蛋白去乙酰化酶抑制剂部分重新激活了β-珠蛋白(L1)的转录。该结果表明,β-珠蛋白(L1)等位基因转录率降低与染色质结构改变有关。因此,β-珠蛋白基因内含子 L1 插入引起的分子缺陷代表了β-地中海贫血的一种新病因。

相似文献

1
β-Thalassemia due to intronic LINE-1 insertion in the β-globin gene (HBB): molecular mechanisms underlying reduced transcript levels of the β-globin(L1) allele.β-地中海贫血由于内含子中的 LINE-1 插入到β-珠蛋白基因(HBB)中:β-珠蛋白(L1)等位基因转录水平降低的分子机制。
Hum Mutat. 2013 Oct;34(10):1361-5. doi: 10.1002/humu.22383. Epub 2013 Aug 13.
2
Amelioration of beta654-thalassemia in mouse model with the knockdown of aberrantly spliced beta-globin mRNA.通过敲低异常剪接的β-珠蛋白mRNA改善小鼠模型中的β654-地中海贫血。
J Genet Genomics. 2008 Oct;35(10):595-601. doi: 10.1016/S1673-8527(08)60080-6.
3
The Effect of Nonsense Mediated Decay on Transcriptional Activity Within the Novel β-Thalassemia Mutation HBB: c.129delT.无义介导的mRNA降解对新型β地中海贫血突变HBB:c.129delT转录活性的影响
Hemoglobin. 2015;39(5):334-9. doi: 10.3109/03630269.2015.1065270. Epub 2015 Jul 24.
4
Relative and Absolute Quantification of Aberrant and Normal Splice Variants in β-Thalassemia.β-地中海贫血中异常和正常剪接变异的相对和绝对定量。
Int J Mol Sci. 2020 Sep 11;21(18):6671. doi: 10.3390/ijms21186671.
5
[Methylation status of γ-globin gene promoter in β-thalassemia major].重型β地中海贫血中γ珠蛋白基因启动子的甲基化状态
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2012 Jun;20(3):642-5.
6
Characterization of Two Deep Intronic Variants on the β-Globin Gene with Inconsistent Interpretations of Clinical Significance.
Hemoglobin. 2018 Mar;42(2):126-128. doi: 10.1080/03630269.2018.1473255. Epub 2018 Jul 26.
7
The molecular characterization of Beta globin gene in thalassemia patients reveals rare and a novel mutations in Pakistani population.地中海贫血患者中β珠蛋白基因的分子特征揭示了巴基斯坦人群中罕见的和新的突变。
Eur J Med Genet. 2016 Aug;59(8):355-62. doi: 10.1016/j.ejmg.2016.05.016. Epub 2016 Jun 1.
8
A Novel Frameshift Mutation at Codons 138/139 (HBB: c.417_418insT) on the β-Globin Gene Leads to β-Thalassemia.β-珠蛋白基因第138/139密码子处(HBB: c.417_418insT)的一种新型移码突变导致β地中海贫血。
Hemoglobin. 2017 Jan;41(1):59-60. doi: 10.1080/03630269.2017.1295986. Epub 2017 May 1.
9
Characterization of the IVS-II-821 (A>C) (: c.316-30A>C) Mutation in a β-Thalassemia Phenotype in Iran.伊朗β地中海贫血表型中IVS-II-821(A>C)(: c.316-30A>C)突变的特征分析
Hemoglobin. 2019 Jan;43(1):23-26. doi: 10.1080/03630269.2019.1592760.
10
Hb Knossos (HBB: c.82G > T), β-globin CD 5 (-CT) (HBB: c.17_18delCT) and δ-globin CD 59 (-a) (HBD: c.179delA) mutations in a Syrian patient with β-thalassemia intermedia.一位叙利亚中间型β-地中海贫血患者存在 Hb Knossos(HBB:c.82G>T)、β-珠蛋白基因 CD5-CT(HBB:c.17_18delCT)和 δ-珠蛋白基因 CD59-a(HBD:c.179delA)突变。
BMC Pediatr. 2019 Feb 18;19(1):61. doi: 10.1186/s12887-019-1435-5.

引用本文的文献

1
LINE-1 transposition into murine Thyroglobulin results in congenital thyroid dysplasia.LINE-1转座到小鼠甲状腺球蛋白中会导致先天性甲状腺发育异常。
PLoS One. 2025 Jul 8;20(7):e0325493. doi: 10.1371/journal.pone.0325493. eCollection 2025.
2
Transposable Elements and Human Diseases: Mechanisms and Implication in the Response to Environmental Pollutants.转座元件与人类疾病:在应对环境污染物中的作用机制及意义。
Int J Mol Sci. 2022 Feb 25;23(5):2551. doi: 10.3390/ijms23052551.
3
The Mobile Element Locator Tool (MELT): population-scale mobile element discovery and biology.移动元件定位工具(MELT):大规模移动元件发现与生物学。
Genome Res. 2017 Nov;27(11):1916-1929. doi: 10.1101/gr.218032.116. Epub 2017 Aug 30.

本文引用的文献

1
Active human retrotransposons: variation and disease.活跃的人类反转录转座子:变异与疾病。
Curr Opin Genet Dev. 2012 Jun;22(3):191-203. doi: 10.1016/j.gde.2012.02.006. Epub 2012 Mar 8.
2
Epigenetic silencing of engineered L1 retrotransposition events in human embryonic carcinoma cells.人类胚胎癌细胞中工程化 L1 逆转座子事件的表观遗传沉默。
Nature. 2010 Aug 5;466(7307):769-73. doi: 10.1038/nature09209.
3
Epigenetic control of mammalian LINE-1 retrotransposon by retinoblastoma proteins.视网膜母细胞瘤蛋白对哺乳动物长散在重复序列1逆转座子的表观遗传控制。
Mutat Res. 2009 Jun 1;665(1-2):20-8. doi: 10.1016/j.mrfmmm.2009.02.011. Epub 2009 Mar 9.
4
Mechanisms of resistance to 5-aza-2'-deoxycytidine in human cancer cell lines.人类癌细胞系对5-氮杂-2'-脱氧胞苷的耐药机制。
Blood. 2009 Jan 15;113(3):659-67. doi: 10.1182/blood-2008-02-140038. Epub 2008 Oct 17.
5
Neither DNA hypomethylation nor changes in the kinetics of erythroid differentiation explain 5-azacytidine's ability to induce human fetal hemoglobin.DNA低甲基化和红系分化动力学的改变均无法解释5-氮杂胞苷诱导人胎儿血红蛋白的能力。
Blood. 2008 Jan 1;111(1):411-20. doi: 10.1182/blood-2007-06-093948. Epub 2007 Oct 4.
6
A mouse model for nonsense mutation bypass therapy shows a dramatic multiday response to geneticin.一种用于无义突变旁路治疗的小鼠模型显示出对遗传霉素的显著多日反应。
Proc Natl Acad Sci U S A. 2007 Sep 25;104(39):15394-9. doi: 10.1073/pnas.0610878104. Epub 2007 Sep 19.
7
Developmental- and differentiation-specific patterns of human gamma- and beta-globin promoter DNA methylation.人类γ-和β-珠蛋白启动子DNA甲基化的发育和分化特异性模式。
Blood. 2007 Aug 15;110(4):1343-52. doi: 10.1182/blood-2007-01-068635. Epub 2007 Apr 24.
8
Gene-breaking: a new paradigm for human retrotransposon-mediated gene evolution.基因破坏:人类逆转录转座子介导的基因进化的新范式。
Genome Res. 2005 Aug;15(8):1073-8. doi: 10.1101/gr.3688905. Epub 2005 Jul 15.
9
Transcriptional disruption by the L1 retrotransposon and implications for mammalian transcriptomes.L1反转录转座子引起的转录干扰及其对哺乳动物转录组的影响。
Nature. 2004 May 20;429(6989):268-74. doi: 10.1038/nature02536.
10
The histone deacetylase inhibitor, trichostatin A, reactivates the developmentally silenced gamma globin expression in somatic cell hybrids and induces gamma gene expression in adult BFUe cultures.组蛋白去乙酰化酶抑制剂曲古抑菌素A可使体细胞杂种中发育沉默的γ珠蛋白表达重新激活,并在成人爆式红系集落形成单位培养物中诱导γ基因表达。
Blood Cells Mol Dis. 2003 May-Jun;30(3):254-7. doi: 10.1016/s1079-9796(03)00024-x.